Browsing by Author Zamora, Lurdes

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 6 to 11 of 11 < previous 
Issue DateTitleAuthor(s)
3-Nov-2022Genomics improves risk stratifi cation of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trialsGonzález Gil, Celia; Morgades, Mireia; Lopes, Thaysa; Fuster Tormo, Francisco; García Chica, Jesús; Zhao, Ran; Montesinos, Pau; Torrent, Anna; Diaz Beya, Marina; Coll, Rosa; Hermosín, Lourdes; Mercadal, Santiago; González Campos, José; Zamora, Lurdes; Artola, Teresa; Vall Llovera, Ferran; Tormo, Mar; Gil Cortés, Cristina; Barba, Pere; Novo, Andrés; Ribera, Jordi; Bernal, Teresa; López de Ugarriza, Paula; Queipo de Llano, María Paz; Martínez Sánchez, Pilar; Giménez, Alicia; González Martínez, Teresa; Cladera, Antonia; Cervera, José; Fernández Martín, Rosa; Ardaiz, María Ángeles; Vidal, María Jesús; Baena, Ángela; López Bigas, Nuria; Bigas Salvans, Anna; Maciejewski, Jaroslaw; Orfao, Alberto; Ribera, Josep Maria; Genescà, Eulàlia
16-Jul-2021Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with ImatinibMarcé, Sílvia; Xicoy, Blanca; García, Olga; Cabezón, Marta; Estrada, Natalia; Vélez, Patricia; Boqué, Concepción; Sagüés, Miguel; Angona, Anna; Teruel Montoya, Raúl; Ferrer Marín, Francisca; Amat, Paula; Hernández Boluda, Juan Carlos; Ibarra, Mariana; Anguita, Eduardo; Cortés, Montserrat; Fernández Ruiz, Andrés; Fontanals, Sandra; Zamora, Lurdes; Grupo Español de Leucemia Mieloide Crónica (GELMC)
30-Nov-2021Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia PatientsEstrada, Natalia; Xicoy, Blanca; Beier, Fabian; Garcia, Olga; Morales, Cristian; Boqué, Concepción; Sagüés, Miguel; Ventura Ferreira, Mónica S.; Vallansot, Rolando; Marcé, Sílvia; Cabezón, Marta; Brümmendorf, Tim H.; Zamora, Lurdes
18-Oct-2021Inhibition of CBP synergizes with the RNA-dependent mechanisms of Azacitidine by limiting protein synthesisDiesch, Jeannine; Pannérer, Marguerite Marie Le; Winkler, René; Casquero, Raquel; Muhar, Matthias; Van Der Garde, Mark; Maher, Michael; Martínez Herráez, Carolina; Bech Serra, Joan J.; Fellner, Michaela; Rathert, Philipp; Brooks, Nigel; Zamora, Lurdes; Gentilella, Antonio; Torre, Carolina de la; Zuber, Johannes; Götze, Katharina S.; Buschbeck, Marcus
19-Dec-2023NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapyHurtado Navarro, Laura; Cuenca Zamora, Ernesto José; Zamora, Lurdes; Bellosillo, Beatriz; Such, Esperanza; Soler Espejo, Eva; Martínez Banaclocha, Helios; Hernández Rivas, Jesús M.; Marco Ayala, Javier; Martínez Alarcón, Laura; Linares Latorre, Lola; García Ávila, Sara; Amat Martínez, Paula; González, Teresa; Arnan, Montserrat; Pomares Marín, Helena; Carreño Tarragona, Gonzalo; Chen Liang, Tzu Hua; Herranz, María T.; García Palenciano, Carlos; Morales, María Luz; Jerez, Andrés; Lozano, María L.; Teruel Montoya, Raúl; Pelegrín, Pablo; Ferrer Marín, Francisca
30-Aug-2016Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic featuresPalomo, Laura; Garcia, Olga; Arnan, Montserrat; Xicoy Cirici, Blanca; Fuster, Francisco; Cabezón, Marta; Coll, Rosa; Ademà, Vera; Grau, Javier; Jimenez, Maria Jose; Pomares, Helena; Marcé Roca, Silvia; Mallo, Mar; Millá, Fuensanta; Alonso Sanz, Esther; Sureda, Anna; Gallardo, David; Feliu, Evarist; Ribera, Josep Maria; Solé Ristol, Francesc; Zamora, Lurdes